Broadwood Partners Reiterates Opposition to STAAR Surgical's Sale to Alcon Following Conclusion of Performative Go-Shop Process
Businesswire·2025-12-08 18:28公司股权与交易动态 - Broadwood Partners及其关联方持有STAAR Surgical Company 30.2%的流通普通股 [1] - Broadwood作为大股东继续反对STAAR Surgical Company以当前交易条款出售给Alcon Inc的提议 [1] - 反对意见源于公司此前进行的交易流程存在缺陷 [1]